Diabetes research collaboration can pave the way for innovation
Metformin is often described as the first-line medication for the treatment of type 2 diabetes. However, not all patients respond to the drug. Researchers at Lund University have discovered a combination of biomarkers that can predict which patients will benefit from the treatment. This work is now continuing in order to confirm the results in a larger patient group, with the intention of developi
https://www.lunduniversity.lu.se/article/diabetes-research-collaboration-can-pave-way-innovation - 2025-09-29